Cytoglobin, the newest member of the globin family, functions as a tumor suppressor gene.

Cytoglobin (CYGB) is a recently discovered vertebrate globin distantly related to myoglobin with unknown function. CYGB is assigned to chromosomal region 17q25, which is frequently lost in multiple malignancies. Previous studies failed to detect evidence for mutations in the CYGB gene. Recent studies provided preliminary evidence for increased methylation of the gene in lung cancer. Our study was aimed at investigating the role of CYGB as a tumor suppressor gene. By nested methylation-specific DNA sequencing analysis of lung and breast cancer cell lines and bronchial and mammary epithelial cell lines, we identified that methylation of a 110-bp CpG-rich segment of the CYGB promoter was correlated with gene silencing. We specifically targeted this sequence and developed a quantitative methylation-specific PCR assay, suitable for high-throughput analysis. We showed that the tumor specificity of CYGB methylation in discriminating patients with and without lung cancer, using biopsies and sputum samples. We further showed the tumor specificity of this assay with multiple other epithelial and hematologic malignancies. To show tumor suppressor activity of CYGB, we performed the following: (a) RNA interference-mediated knockdown of CYGB gene on colony formation in a CYGB expression-positive lung cancer cell line, resulting in increased colony formation; (b) enforced gene expression in CYGB expression-negative lung and breast cancer cell lines, reducing colony formation; and (c) identification of potential proximate targets down-stream of the CYGB genes. Our data constitute the first direct functional evidence for CYGB, the newest member of the globin family, as a tumor suppressor gene.

[1]  David E. Misek,et al.  Analysis of Tumor-Host Interactions by Gene Expression Profiling of Lung Adenocarcinoma Xenografts Identifies Genes Involved in Tumor Formation , 2005, Molecular Cancer Research.

[2]  J. E. Langan,et al.  Novel microsatellite markers and single nucleotide polymorphisms refine the tylosis with oesophageal cancer (TOC) minimal region on 17q25 to 42.5 kb: sequencing does not identify the causative gene , 2004, Human Genetics.

[3]  V. Notario,et al.  PCPH/ENTPD5 expression enhances the invasiveness of human prostate cancer cells by a protein kinase C delta-dependent mechanism. , 2007, Cancer research.

[4]  J. Minna,et al.  RNA interference-mediated knockdown of DNA methyltransferase 1 leads to promoter demethylation and gene re-expression in human lung and breast cancer cells. , 2004, Cancer research.

[5]  Hirofumi Nakayama,et al.  Molecular-pathological prognostic factors of gastric cancer: a review , 2005, Gastric Cancer.

[6]  Christoph Plass,et al.  Epigenetic regulation of the tumor suppressor gene TCF21 on 6q23-q24 in lung and head and neck cancer. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[7]  M. Daemen,et al.  Dead or alive: gene expression profiles of advanced atherosclerotic plaques from autopsy and surgery. , 2007, Physiological genomics.

[8]  S. Seki,et al.  Cytoglobin/STAP, its unique localization in splanchnic fibroblast-like cells and function in organ fibrogenesis , 2004, Laboratory Investigation.

[9]  David Yang,et al.  Identification of cervical cancer markers by cDNA and tissue microarrays. , 2003, Cancer research.

[10]  A. Levitzki,et al.  ROS, stress‐activated kinases and stress signaling in cancer , 2002, EMBO reports.

[11]  I. Wistuba,et al.  Application of a methylation gene panel by quantitative PCR for lung cancers. , 2007, Cancer letters.

[12]  B. Miroux,et al.  Disruption of the uncoupling protein-2 gene in mice reveals a role in immunity and reactive oxygen species production , 2000, Nature Genetics.

[13]  J. Minna,et al.  Establishment and validation of real-time polymerase chain reaction method for CDH1 promoter methylation. , 2002, The American journal of pathology.

[14]  K. Kojima,et al.  Methylated TMS1 and DAPK genes predict prognosis and response to chemotherapy in gastric cancer , 2008, International journal of cancer.

[15]  J. Wands,et al.  Expression of Uncoupling Protein-2 in Human Colon Cancer , 2004, Clinical Cancer Research.

[16]  J. Wands,et al.  The mitochondrial uncoupling protein-2 promotes chemoresistance in cancer cells. , 2008, Cancer research.

[17]  E. Nevo,et al.  Cytoglobin Is a Respiratory Protein in Connective Tissue and Neurons, Which Is Up-regulated by Hypoxia* , 2004, Journal of Biological Chemistry.

[18]  M. Hargrove,et al.  A Ubiquitously Expressed Human Hexacoordinate Hemoglobin* , 2002, The Journal of Biological Chemistry.

[19]  Peter A. Jones,et al.  Cancer-epigenetics comes of age , 1999, Nature Genetics.

[20]  P. Conget,et al.  Validation in mesenchymal progenitor cells of a mutation-independent ex vivo approach to gene therapy for osteogenesis imperfecta. , 2002, Human molecular genetics.

[21]  K. Dewar,et al.  Loss of heterozygosity and transcriptome analyses of a 1.2 Mb candidate ovarian cancer tumor suppressor locus region at 17q25.1‐q25.2 , 2005, Molecular carcinogenesis.

[22]  R. Hardison,et al.  A brief history of hemoglobins: plant, animal, protist, and bacteria. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[23]  J. E. Langan,et al.  Characterization of a 500 kb region on 17q25 and the exclusion of candidate genes as the familial Tylosis Oesophageal Cancer (TOC) locus , 2002, Oncogene.

[24]  S. Toyooka,et al.  Aberrant methylation of HIN‐1 (high in normal‐1) is a frequent event in many human malignancies , 2005, International journal of cancer.

[25]  V. Falanga,et al.  Low oxygen tension stimulates collagen synthesis and COL1A1 transcription through the action of TGF‐β1 , 2002, Journal of cellular physiology.

[26]  M. Westerfield,et al.  Characterization of paired tumor and non‐tumor cell lines established from patients with breast cancer , 1998, International journal of cancer.

[27]  M. Szyf,et al.  Human DNA methyltransferase gene DNMT1 is regulated by the APC pathway. , 2003, Carcinogenesis.

[28]  J. Minna,et al.  Somatic mutations of the HER2 kinase domain in lung adenocarcinomas. , 2005, Cancer research.

[29]  A. J. Lambert,et al.  A signalling role for 4‐hydroxy‐2‐nonenal in regulation of mitochondrial uncoupling , 2003, The EMBO journal.

[30]  J. Herman,et al.  Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[31]  J. Minna,et al.  Multiple oncogenic changes (K-RAS(V12), p53 knockdown, mutant EGFRs, p16 bypass, telomerase) are not sufficient to confer a full malignant phenotype on human bronchial epithelial cells. , 2006, Cancer research.

[32]  R. Weber,et al.  Functional adaptation and its molecular basis in vertebrate hemoglobins, neuroglobins and cytoglobins , 2004, Respiratory Physiology & Neurobiology.

[33]  Luigi Marchionni,et al.  Gene expression profiling of advanced ovarian cancer: characterization of a molecular signature involving fibroblast growth factor 2 , 2004, Oncogene.

[34]  T. Burmester,et al.  Cytoglobin: a novel globin type ubiquitously expressed in vertebrate tissues. , 2002, Molecular biology and evolution.

[35]  J. Pollack,et al.  Immortalization of Human Bronchial Epithelial Cells in the Absence of Viral Oncoproteins , 2004, Cancer Research.

[36]  D. Liao,et al.  Gene expression profiles in primary pancreatic tumors and metastatic lesions of Ela-c-myc transgenic mice , 2008, Molecular Cancer.

[37]  T. Liloglou,et al.  Frequent genetic and epigenetic abnormalities contribute to the deregulation of cytoglobin in non-small cell lung cancer. , 2006, Human molecular genetics.